Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Inventory (2019 - 2025)

Historic Inventory for Sunshine Biopharma (SBFMW) over the last 7 years, with Q3 2025 value amounting to $14.1 million.

  • Sunshine Biopharma's Inventory rose 4320.43% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 4320.43%. This contributed to the annual value of $11.3 million for FY2024, which is 9666.24% up from last year.
  • Per Sunshine Biopharma's latest filing, its Inventory stood at $14.1 million for Q3 2025, which was up 4320.43% from $13.0 million recorded in Q2 2025.
  • Sunshine Biopharma's Inventory's 5-year high stood at $14.1 million during Q3 2025, with a 5-year trough of $26660.0 in Q1 2021.
  • Over the past 5 years, Sunshine Biopharma's median Inventory value was $4.3 million (recorded in 2023), while the average stood at $5.2 million.
  • As far as peak fluctuations go, Sunshine Biopharma's Inventory soared by 301400.38% in 2022, and later soared by 4320.43% in 2025.
  • Sunshine Biopharma's Inventory (Quarter) stood at $105650.0 in 2021, then surged by 3014.0% to $3.3 million in 2022, then skyrocketed by 74.31% to $5.7 million in 2023, then surged by 96.66% to $11.3 million in 2024, then rose by 24.7% to $14.1 million in 2025.
  • Its Inventory stands at $14.1 million for Q3 2025, versus $13.0 million for Q2 2025 and $11.9 million for Q1 2025.